Comparing the effectiveness and costs of Bevacizumab to Ranibizumab in patients with Diabetic Macular Edema: a randomized clinical trial (the BRDME study)

BACKGROUND: The effectiveness of ranibizumab in the treatment of diabetic macular edema has been proven with large clinical trials. For bevacizumab only two clinical trials have been published and a head-to-head comparison is lacking to date. However, if proved non-inferior to ranibizumab, use of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Schauwvlieghe, A.M.E., Dijkman, G., Hooymans, J.M., Verbraak, F.D., Hoyng, C.B., Dijkgraaf, M.G.W., Van Leeuwen, R., Vingerling, J.R., Moll, A.C., Schlingemann, Reinier O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4491889/
https://www.ncbi.nlm.nih.gov/pubmed/26149170
http://dx.doi.org/10.1186/s12886-015-0043-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4491889/
https://www.ncbi.nlm.nih.gov/pubmed/26149170
http://dx.doi.org/10.1186/s12886-015-0043-x

Ejemplares similares